This item tests recognizing scabies and knowing the best first-line therapy for it. The intense itching and a rash that involves the hands and groin areas fit classic scabies, an ectoparasitic infestation caused by Sarcoptes scabiei. The photograph in such questions typically shows the papules and burrows characteristic of scabies, which explains why a treatment that directly targets the mites is chosen. Topical permethrin 5% cream is the recommended first-line therapy. It’s specifically effective against the mites and their eggs. The usual approach is to apply the cream to the entire body from the neck down (and include hands, feet, and genital area), leave it on for about 8–14 hours, then wash off. Because scabies spreads readily in close contacts and through shared bedding and clothing, all household or close contacts should be treated at the same time, and contaminated items should be laundered or sealed in plastic bags for several days. A second dose may be considered if symptoms persist or if the infestation is heavy. The other options don’t address the underlying parasite. Fluconazole is for fungal infections, mupirocin targets bacteria, and metronidazole targets anaerobic bacteria or certain protozoa, not scabies.

Antibiotic stewardship in urgent care centers centers on using antibiotics responsibly to treat bacterial infections while minimizing harm from side effects and resistance. The best approach is to use narrow-spectrum agents when a bacterial infection is likely and targeted, avoid antibiotics for illnesses that are likely viral, and tailor how long and by what route the medicine is given to the specific situation. It also means avoiding unnecessary broad-spectrum drugs and using culture or sensitivity testing when available to guide therapy so you can de-escalate to the most appropriate option. Educating patients about what to expect and when antibiotics are actually needed helps reduce pressure to prescribe inappropriately. This combination protects patient safety, reduces adverse events and costs, and helps keep effective antibiotics available for when they’re truly needed. Options that promote treating viral infections with antibiotics, rely on broad-spectrum agents without testing, or skip cultures miss these essential stewardship steps.

Severe drug-induced skin reactions can show up within days to weeks after starting a new medicine, and they often present as widespread, painful, red skin that may involve tenderness and sometimes mucous membranes. In this scenario, starting a new antibiotic five days ago with diffuse tender erythroderma strongly points to a serious cutaneous adverse reaction, most classically Stevens-Johnson syndrome/TEN. Trimethoprim-sulfamethoxazole is a well-known trigger for these severe reactions, particularly because of its sulfonamide component. The immune system can mount a cytotoxic attack on keratinocytes in response to the drug or its metabolites, leading to widespread skin damage and detachment characteristic of SJS/TEN. While other antibiotics can cause rashes, they are less commonly associated with this severe, widespread, tender eruption, making TMP-SMX the most likely culprit in this presentation. If this is suspected, discontinue the drug immediately and seek urgent medical evaluation, as SJS/TEN require prompt assessment and supportive care.

ST-segment elevation in two or more contiguous leads signals acute transmural injury from a coronary occlusion, which is the hallmark of STEMI and requires urgent reperfusion. The elevation reflects current of injury across a regional area of the heart, so leads that look at the same area (contiguous) will all show elevated ST segments. This is why it’s the best answer: it directly indicates an ongoing, life-threatening myocardial infarction needing emergent care. Other patterns don’t indicate an acute STEMI in the same way. New Q waves without symptoms suggest a prior infarct. Isolated T-wave inversion can occur with ischemia or repolarization changes but isn’t diagnostic of STEMI. A normal EKG with chest pain does not point to STEMI.